1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Route of Administration
• Market Snapshot, By Application
• Market Snapshot, By Distribution Channel
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Market Trends
• Epidemiology
• Recent Developments
• Acquisitions and Partnerships Scenario
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis
• Key Highlights

4. China Mesalazine Market, By Route of Administration, 2021 – 2033, (USD Million)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Oral
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
• Rectal
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)

5. China Mesalazine Market, By Application, 2021 – 2033, (USD Million)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Ulcerative Colitis
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
• Crohn's Disease
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
• Inflammatory Bowel Disease
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)

6. China Mesalazine Market, By Distribution Channel, 2021 – 2033, (USD Million)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Hospital Pharmacies
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
• Retail Pharmacies
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
• Online Pharmacies
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)

7. Competitive Landscape

• Zhejiang Hengkang Pharmaceutical Co. Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Jiangsu Jubang Pharmaceutical Co., Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• ALP Pharm Beijing Co., Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Shanghai Pharmaceuticals Holding Co Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Heilongjiang Tianhong Pharmaceutical Co., Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• AbbVie Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• F. Hoffmann-La Roche AG 
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Takeda Pharmaceuticals Company Limited
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• GSK Plc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Tillotts Pharma AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Novartis AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Salix Pharmaceuticals
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• FERRING B.V.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Viatris Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Dr. Falk Pharma GmbH
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies

8. Section

• Research Methodology
• About Us